Intercept Pharmaceuticals Inc.

NAS: ICPT

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders

/marketstate/country/us

Intercept Pharmaceuticals Inc.

After Hours

ICPT

/zigman2/quotes/202434567/composite

15.35

Change

-0.06 -0.39%

Volume

Volume 25,626

Jan 21, 2022, 7:45 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202434567/composite

Previous close

$ 17.00

$ 15.41

Change

-1.59 -9.35%

Day low

Day high

$15.30

$17.45

Open: 16.86

52 week low

52 week high

$11.60

$38.94

Market cap

$455.32M

Average volume

845,923

P/E ratio

N/A

Rev. per Employee

$711,510

EPS

-3.25

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:

Indexes

Dow(INDU) INDU
Nasdaq (COMP) COMP
S&P 500 (SPX) SPX
Global Dow (GDOW) GDOW

/news/latest/company/us/icpt

MarketWatch News on ICPT

Intercept Pharmaceuticals stock price target cut to $31 from $43 at Canaccord Genuity

8:22 a.m. Aug. 3, 2021

- Tomi Kilgore
The FDA's Biogen Decision Will Cause Waves Across Biotech

8:20 p.m. June 1, 2021

- Barron's Online
Intercept Pharmaceuticals downgraded to neutral from buy at B. Riley

6:23 a.m. May 26, 2021

- Tomi Kilgore
Biotechs Can't Cure This Liver Disease. The Latest Failure Crushed the Sector.

4:45 p.m. May 25, 2021

- Barron's Online
Intercept Pharmaceuticals stock price target cut to $74 from $97 at B. Riley FBR

7:28 a.m. Nov. 20, 2020

- Tomi Kilgore
Intercept Pharmaceuticals upgraded to outperform from market perform at Raymond James

7:47 a.m. Nov. 10, 2020

- Tomi Kilgore
Intercept Pharmaceuticals Will Lay Off a Quarter of Its Staff as NASH Dream Fades

10:20 a.m. Sept. 2, 2020

- Barron's Online
Intercept shares gain after it announces layoffs

7:19 a.m. Sept. 2, 2020

- Jaimy Lee
A Top Contender Drops Out of Race for a NASH Drug

10:15 a.m. July 23, 2020

- Barron's Online
Biogen Submits Troubled Alzheimer’s Drug for FDA Approval

11:07 a.m. July 8, 2020

- Barron's Online
Analysts Are Downgrading Intercept Pharmaceuticals. Here’s Why.

10:53 a.m. June 30, 2020

- Barron's Online
Intercept Pharmaceuticals downgraded to market perform at BMO Capital

8:07 a.m. June 30, 2020

- Tomi Kilgore
Intercept Pharmaceuticals stock price target cut to $97 from $158 at B. Riley FBR

6:53 a.m. June 30, 2020

- Tomi Kilgore
Intercept Pharmaceuticals stock price target cut to $50 from $89 at SVB Leerink

5:11 a.m. June 30, 2020

- Tomi Kilgore
Intercept Shares Tumble on NASH Disappointment

3:05 p.m. June 29, 2020

- Barron's Online
Intercept Pharmaceuticals receives FDA Complete Response Letter for treatment for fibrosis due to NASH

6:24 a.m. June 29, 2020

- Ciara Linnane
Intercept's stock plunges 35% premarket after receiving CRL from FDA for treatment of fibrosis due to NASH

6:17 a.m. June 29, 2020

- Tomi Kilgore
Intercept Pharmaceuticals receives FDA letter for its treatment for fibrosis due to NASH

6:15 a.m. June 29, 2020

- Ciara Linnane
Intercept Pharmaceuticals shares slide 35% premarket

6:15 a.m. June 29, 2020

- Ciara Linnane
Intercept Pharmaceuticals started at outperform with $107 stock price target at BMO Capital

7:35 a.m. June 5, 2020

- Tomi Kilgore
Loading more headlines...